Xiaonan Zhang

Bengbu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Integrating machine learning and immune infiltration analysis to identify core genes and construct a diagnostic model for type 2 diabetes mellitus.

Integrating machine learning and immune infiltration analysis to identify core genes and construct a diagnostic model for type 2 diabetes mellitus.

Journal: Frontiers in endocrinology

Published: January 18, 2026

Multi-cohort and single-cell profiling of aging genes reveals prognostic and therapeutic targets in breast cancer.

Multi-cohort and single-cell profiling of aging genes reveals prognostic and therapeutic targets in breast cancer.

Journal: iScience

Published: August 12, 2025

The R451 site is critical for PTPN18 to exert tumor suppressive effects in breast cancer through the negative regulatory interacting protein fibrillarin.

The R451 site is critical for PTPN18 to exert tumor suppressive effects in breast cancer through the negative regulatory interacting protein fibrillarin.

Journal: Cell death & disease

Published: April 12, 2025

Artificial intelligence-assisted RNA-binding protein signature for prognostic stratification and therapeutic guidance in breast cancer.

Artificial intelligence-assisted RNA-binding protein signature for prognostic stratification and therapeutic guidance in breast cancer.

Journal: Frontiers in immunology

Published: February 25, 2025

Personalized treatment decision-making using a machine learning-derived lactylation signature for breast cancer prognosis.

Personalized treatment decision-making using a machine learning-derived lactylation signature for breast cancer prognosis.

Journal: Frontiers in immunology

Published: December 05, 2024

Development of a tertiary lymphoid structure-based prognostic model for breast cancer: integrating single-cell sequencing and machine learning to enhance patient outcomes.

Development of a tertiary lymphoid structure-based prognostic model for breast cancer: integrating single-cell sequencing and machine learning to enhance patient outcomes.

Journal: Frontiers in immunology

Published: November 26, 2024

Machine learning on transcription factor expression profiles for precision breast cancer therapy.

Machine learning on transcription factor expression profiles for precision breast cancer therapy.

Journal: Cancer cell international

Published: September 24, 2024

Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures.

Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures.

Journal: Frontiers in immunology

Published: December 31, 2022

Tetramethylpyrazine ameliorates acute lung injury by regulating the Rac1/LIMK1 signaling pathway.

Tetramethylpyrazine ameliorates acute lung injury by regulating the Rac1/LIMK1 signaling pathway.

Journal: Frontiers in pharmacology

Published: July 27, 2022

Pan-cancer analyses of classical protein tyrosine phosphatases and phosphatase-targeted therapy in cancer.

Pan-cancer analyses of classical protein tyrosine phosphatases and phosphatase-targeted therapy in cancer.

Journal: Frontiers in immunology

Published: June 24, 2022

Nuclear import of PTPN18 inhibits breast cancer metastasis mediated by MVP and importin β2.

Nuclear import of PTPN18 inhibits breast cancer metastasis mediated by MVP and importin β2.

Journal: Cell death & disease

Published: March 04, 2022

A TP53 Related Immune Prognostic Model for the Prediction of Clinical Outcomes and Therapeutic Responses in Lung Adenocarcinoma.

A TP53 Related Immune Prognostic Model for the Prediction of Clinical Outcomes and Therapeutic Responses in Lung Adenocarcinoma.

Journal: Frontiers in immunology

Published: February 15, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026